Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) went up by 18.95% from its latest closing price compared to the recent 1-year high of $31.24. The company’s stock price has collected 14.91% of gains in the last five trading sessions.
Is It Worth Investing in Clarus Therapeutics Holdings Inc. (NASDAQ :CRXT) Right Now?
Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Clarus Therapeutics Holdings Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $2.63, which is $2.83 above the current price. Today, the average trading volume of CRXT was 13.95M shares.
CRXT’s Market Performance
CRXT stocks went up by 14.91% for the week, with a monthly jump of 7.76% and a quarterly performance of -64.20%, while its annual performance rate touched -95.81%. The volatility ratio for the week stands at 12.40% while the volatility levels for the past 30 days are set at 14.46% for Clarus Therapeutics Holdings Inc. The simple moving average for the period of the last 20 days is 1.55% for CRXT stocks with a simple moving average of -84.21% for the last 200 days.
CRXT Trading at -38.37% from the 50-Day Moving Average
After a stumble in the market that brought CRXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.65% of loss for the given period.
Volatility was left at 14.46%, however, over the last 30 days, the volatility rate increased by 12.40%, as shares sank -0.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -65.38% lower at present.
During the last 5 trading sessions, CRXT rose by +14.91%, which changed the moving average for the period of 200-days by -94.49% in comparison to the 20-day moving average, which settled at $0.4159. In addition, Clarus Therapeutics Holdings Inc. saw -82.62% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CRXT
Current profitability levels for the company are sitting at:
- -284.67 for the present operating margin
- +80.51 for the gross margin
The net margin for Clarus Therapeutics Holdings Inc. stands at -291.02.
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.78.